SESSION 2 – Artificial Intelligence and Machine Learning applied to drug development
Thursday, September 19, 2024 10:45 AM to 11:30 AM · 45 min. (Europe/Zurich)
Ilmac Conference
Ilmac Lausanne
Information
This session will present case studies from key players (industry, startups, research) developing and making use of AI and ML innovations to optimise and accelerate drug development.
Loïc Roch | CEO | Atinary
Jo Varshney | CEO | VeriSim Life
Jean-Philippe Fricker | Chief Systems Architect | Cerebras
Raphëlle Luisier | Genomics & Health Informatics Group Lead | IDIAP Research Institute
Marion Bossy | Global Head of Real-World Evidence | SOPHiA GENETICS
Ilmac Highlights
Conference